Germany · Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 49.33 billion. The enterprise value is 57.22 billion.
| Market Cap | 49.33B |
| Enterprise Value | 57.22B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.43% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 17.22 and the forward PE ratio is 13.41. Merck KGaA's PEG ratio is 2.63.
| PE Ratio | 17.22 |
| Forward PE | 13.41 |
| PS Ratio | 2.32 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 9.25 |
| P/FCF Ratio | 22.80 |
| P/OCF Ratio | 12.94 |
| PEG Ratio | 2.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.61, with an EV/FCF ratio of 26.46.
| EV / Earnings | 19.99 |
| EV / Sales | 2.70 |
| EV / EBITDA | 9.61 |
| EV / EBIT | 13.43 |
| EV / FCF | 26.46 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.24 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 4.35 |
| Interest Coverage | 17.75 |
Financial Efficiency
Return on equity (ROE) is 10.10% and return on invested capital (ROIC) is 6.91%.
| Return on Equity (ROE) | 10.10% |
| Return on Assets (ROA) | 5.48% |
| Return on Invested Capital (ROIC) | 6.91% |
| Return on Capital Employed (ROCE) | 11.36% |
| Revenue Per Employee | 335,956 |
| Profits Per Employee | 45,329 |
| Employee Count | 59,020 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.91 |
Taxes
In the past 12 months, Merck KGaA has paid 764.00 million in taxes.
| Income Tax | 764.00M |
| Effective Tax Rate | 20.99% |
Stock Price Statistics
The stock price has decreased by -24.94% in the last 52 weeks. The beta is 0.64, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -24.94% |
| 50-Day Moving Average | 111.85 |
| 200-Day Moving Average | 119.45 |
| Relative Strength Index (RSI) | 48.88 |
| Average Volume (20 Days) | 329,856 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 21.22 billion and earned 2.86 billion in profits. Earnings per share was 6.59.
| Revenue | 21.22B |
| Gross Profit | 12.45B |
| Operating Income | 4.26B |
| Pretax Income | 3.64B |
| Net Income | 2.86B |
| EBITDA | 5.95B |
| EBIT | 4.26B |
| Earnings Per Share (EPS) | 6.59 |
Balance Sheet
The company has 1.57 billion in cash and 9.40 billion in debt, giving a net cash position of -7.83 billion or -18.01 per share.
| Cash & Cash Equivalents | 1.57B |
| Total Debt | 9.40B |
| Net Cash | -7.83B |
| Net Cash Per Share | -18.01 |
| Equity (Book Value) | 28.33B |
| Book Value Per Share | 65.01 |
| Working Capital | 2.34B |
Cash Flow
In the last 12 months, operating cash flow was 3.81 billion and capital expenditures -1.65 billion, giving a free cash flow of 2.16 billion.
| Operating Cash Flow | 3.81B |
| Capital Expenditures | -1.65B |
| Free Cash Flow | 2.16B |
| FCF Per Share | 4.97 |
Margins
Gross margin is 58.69%, with operating and profit margins of 20.08% and 13.49%.
| Gross Margin | 58.69% |
| Operating Margin | 20.08% |
| Pretax Margin | 17.15% |
| Profit Margin | 13.49% |
| EBITDA Margin | 28.06% |
| EBIT Margin | 20.08% |
| FCF Margin | 10.19% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.94%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 1.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.29% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 2.09% |
| Earnings Yield | 5.80% |
| FCF Yield | 4.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 3.44 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.44 |
| Piotroski F-Score | 7 |